1. Home
  2. ADAG

as of 12-05-2025 4:00pm EST

$1.99
+$0.02
+1.02%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.

Chart Type:
Time Range:
Founded: 2011 Country:
China
China
Employees: N/A City: N/A
Market Cap: 84.8M IPO Year: 2021
Target Price: $8.00 AVG Volume (30 days): 98.5K
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.64 EPS Growth: N/A
52 Week Low/High: $1.30 - $3.16 Next Earning Date: 08-12-2025
Revenue: $103,204 Revenue Growth: -87.35%
Revenue Growth (this year): 6983.06% Revenue Growth (next year): 36.05%

AI-Powered ADAG Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 65.75%
65.75%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: